Long-term Extension Study for Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies
Latest Information Update: 07 Dec 2024
Price :
$35 *
At a glance
- Drugs HMR-59 (Primary)
- Indications Age-related macular degeneration; Dry macular degeneration
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 23 Oct 2024 Planned End Date changed from 29 Aug 2029 to 3 Dec 2029.
- 15 Oct 2024 New trial record